Tupper Colleen - Net Worth and Insider Trading
Tupper Colleen Net Worth
The estimated net worth of Tupper Colleen is at least $2 Million dollars as of 2023-03-22. Tupper Colleen is the EVP & CFO of Collegium Pharmaceutical Inc and owns about 90,304 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $2 Million. Details can be seen in Tupper Colleen's Latest Holdings Summary section.
Transaction Summary of Tupper Colleen
Tupper Colleen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tupper Colleen owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .
Click here to see the complete history of Tupper Colleen’s form 4 insider trades.
Insider Ownership Summary of Tupper Colleen
|Ticker||Comapny||Transaction Date||Type of Owner|
|COLL||Collegium Pharmaceutical Inc||2022-02-10||EVP & Chief Financial Officer|
Tupper Colleen Latest Holdings Summary
Tupper Colleen currently owns a total of 1 stock. Tupper Colleen owns 90,304 shares of Collegium Pharmaceutical Inc (COLL) as of October 4, 2022, with a value of $2 Million.
Latest Holdings of Tupper Colleen
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|COLL||Collegium Pharmaceutical Inc||2022-10-04||90,304||24.89||2,247,667|
Holding Weightings of Tupper Colleen
Tupper Colleen Form 4 Trading Tracker
According to the SEC Form 4 filings, Tupper Colleen has made a total of 1 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 4,350 shares on October 4, 2022, which brought Tupper Colleen around $75,473.
Insider Trading History of Tupper Colleen
Tupper Colleen Trading Performance
Tupper Colleen Ownership Network
Ownership Network List of Tupper Colleen
Ownership Network Relation of Tupper Colleen
Tupper Colleen Owned Company Details
What does Collegium Pharmaceutical Inc do?
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Who are the key executives at Collegium Pharmaceutical Inc?
Tupper Colleen is the EVP & Chief Financial Officer of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and Chief Medical Officer Richard Malamut , and EVP & Chief Commercial Officer Scott Dreyer .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Tupper Colleen made 1 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 4,350. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 164,703 shares made by Joseph Ciaffoni , a net sale of 298,612 shares made by Michael Thomas Heffernan , and a net sale of 60,700 shares made by Shirley R. Kuhlmann .
In summary, during the past 3 months, insiders sold 78,397 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 78,397 shares. During the past 18 months, 562,451 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 562,451 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:COLL Insider Transactions
Tupper Colleen Mailing Address
Above is the net worth, insider trading, and ownership report for Tupper Colleen. You might contact Tupper Colleen via mailing address: C/o Collegium Pharmaceutical, Inc., 100 Technology Center Drive, Stoughton Ma 02072.